David M. Smadja, PhD

Professor of Hematology
Universite Paris Cité
Paris, Ile-de-France, France

I am Full Professor of Hematology in Paris Cité University and European Georges Pompidou Hospital in Paris. After residency and fellowship in Hematology department of European Georges Pompidou hospital, I completed a PhD on “thrombin receptor activation in endothelial progenitor cells” in 2006. Scientific focus of my lab is hemostasis, hemocompatibility of biomaterials and vascular and valvular biology. In 2018, I was elected co-chairman of the Scientific and Standardization Committee on Vascular Biology of the ISTH for endothelial progenitor section. I was the director of the Biosurgical research lab in European Georges Pompidou Hospital between 2019 and 2021. Recently, my team has been involved in identifying urgent questions and challenges of the COVID-19 pandemic on the thrombotic and vascular aspects of the disease.

Presentation(s):

• PB0861 - Soluble ST2 is a Key outcome Biomarker in COVID-19: Insights from Discovery Randomized Trial

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1452 - Adjuvant Cancer Treatment with Brain-Guided Hyperthermia: Reduction in Inflammation and Angiogenic Biomarkers - Insights from a Pilot Biomarker Study

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1021 - Bleeding Events during Extracorporeal Membrane Oxygenation can be predicted by the assessment of Loss in High-Molecular-Weight Multimers of von Willebrand Factor.

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1380 - Circulating Endothelial Cells as Key Predictors of Fatigue in Long COVID Patients

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT